Obesity Phenotypes Causally Affect Cardiac MRI Structure and Induced Non-ischaemic Cardiomyopathy
- PMID: 40395981
- PMCID: PMC12090072
- DOI: 10.15420/cfr.2024.26
Obesity Phenotypes Causally Affect Cardiac MRI Structure and Induced Non-ischaemic Cardiomyopathy
Abstract
Background: The growing obesity epidemic highlights the need to understand how various obesity phenotypes affect myocardial structure and increase non-ischaemic cardiomyopathy (NICM) incidence. The aim of this study was to investigate the causal effect of eight obesity-related traits on NICM and 16 cardiac MRI parameters. Potential mediators between obesity and NICM were also investigated.
Methods: Two-sample Mendelian randomisation was used to explore the causal relationship between eight obesity-related traits and NICM and assess their impact on cardiac MRI indicators. The study also used validation dataset analysis and multivariable Mendelian randomisation to ensure robustness, and mediation Mendelian randomisation analysis to identify metabolic markers as potential mediators.
Results: All eight obesity-related traits demonstrated a causal relationship with NICM, with the relationship between BMI and NICM persisting after adjustment for LDL cholesterol, urate level and hypertension (HTN). These traits also influenced arterial and cardiac structure and function, especially with regard to left ventricular mass. HTN was identified as a significant mediator, with a mediation effect ratio of 31%.
Conclusion: There is a robust causal association between obesity and NICM, and with abnormalities in myocardial structure and function. HTN emerges as a pivotal mediator in the obesity-NICM pathway, underscoring the critical role of managing obesity and HTN in preventing NICM progression.
Keywords: Mendelian randomisation; Obesity; body mass index; hypertension; non-ischaemic cardiomyopathy.
Copyright © The Author(s), 2025. Published by Radcliffe Group Ltd.
Conflict of interest statement
Disclosure: The authors have no conflicts of interest to declare.
Figures





Similar articles
-
Type 1 diabetes, its complications, and non-ischemic cardiomyopathy: a mendelian randomization study of European ancestry.Cardiovasc Diabetol. 2024 Jan 13;23(1):31. doi: 10.1186/s12933-023-02117-7. Cardiovasc Diabetol. 2024. PMID: 38218861 Free PMC article.
-
The causal effect of Alzheimer's disease and family history of Alzheimer's disease on non-ischemic cardiomyopathy and left ventricular structure and function: a Mendelian randomization study.Front Genet. 2024 Jun 5;15:1379865. doi: 10.3389/fgene.2024.1379865. eCollection 2024. Front Genet. 2024. PMID: 38903751 Free PMC article.
-
Causal relationship between Hashimoto's thyroiditis and non-ischemic cardiomyopathy and the mediating role of inflammatory cytokines: Evidence from genetic association analysis.Int J Cardiol. 2025 Mar 1;422:132934. doi: 10.1016/j.ijcard.2024.132934. Epub 2024 Dec 26. Int J Cardiol. 2025. PMID: 39732150
-
Complication rates following ventricular tachycardia ablation in ischaemic and non-ischaemic cardiomyopathies: a systematic review.J Interv Card Electrophysiol. 2022 Jan;63(1):59-67. doi: 10.1007/s10840-021-00948-6. Epub 2021 Jan 29. J Interv Card Electrophysiol. 2022. PMID: 33512605 Free PMC article.
-
Multimodality Imaging to Guide Ventricular Tachycardia Ablation in Patients with Non-ischaemic Cardiomyopathy.Arrhythm Electrophysiol Rev. 2020 Feb 12;8(4):255-264. doi: 10.15420/aer.2019.37.3. Arrhythm Electrophysiol Rev. 2020. PMID: 32685156 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources